Pure Global
NCT05606068

A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy - Expansion Study

National University Hospital, Singapore·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Chemotherapy-induced Peripheral Neuropathy
Drug/Device/Intervention
Paxman Limb Cryocompression System (PLCS)
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
National University Hospital, Singapore
Location
Singapore,Singapore, Singapore
Timeline & enrollment
Phase
N/A
Start date
Nov 03, 2022
End date
Nov 01, 2024
Enrollment
80 participants
Primary outcome

Incidence of Treatment-Emergent Adverse Events in cancer patients, over the duration of a limb cryocompression cycle, as assessed by Common Terminology Criteria for Adverse Events 5.0,Difference in qualitative symptom scores using the European Organisation of Research and Treatment of Cancer Quality of Life Questionnaire-CIPN twenty-item scale

Summary

The study conducted on cancer patients is designed to test safety and efficacy of limb
 hypothermia in cancer patients using the new Paxman Limb Cryocompression System (PLCS).
 Ultimately this will lead to the development of a therapy regime that will help to prevent
 chemotherapy-induced neuropathy in cancer patients.

ICD-10 classifications
Drug-induced polyneuropathyParaneoplastic neuromyopathy and neuropathyPolyneuropathy due to other toxic agentsIdiopathic peripheral autonomic neuropathyIdiopathic progressive neuropathy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05606068
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05606068 through Pure Global AI's free database. This phase not specified trial is sponsored by National University Hospital, Singapore and is currently Not yet recruiting. The study focuses on Chemotherapy-induced Peripheral Neuropathy. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.